hyperparathyroidism
HYPERPARATHYROIDISM

Hyperparathyroidism is a condition wherein there is an excessive production of parathyroid hormone (PTH).

Primary hyperparathyroidism is the most common endocrine disorder and an important cause of hypercalcemia in ambulatory patients.

Classic signs and symptoms include bone disease, kidney stones and hypercalcinosis.

Primary goal of pharmacological therapy is to normalize calcium levels.

 

  1. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologist and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005 Jan;11(1):49-54. PMID: 16033736
  2. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin ENdocrinol Metab. 2014 Oct;99(10):3561-3569. doi: 10.1210/jc.2014-1413. Accessed 08 Nov 2017. PMID: 25162665
  3. Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Primary hyperparathyroidism. May 02, 2016. Nat Rev Dis Primers. 2017 Sep. doi: 10.1038/nrdp.2016.33. PMID: 27194212
  4. Cheng V. Hyperparathyroidism. In: Ferri, F F. Ferri's Clinical Advisor 2018. Philadelphia, PA: Elsevier, Inc; 2018. 655-656. :655-656.e1.
  5. Christakis I A, Perrier N D. Evaluation and management of persistent or recurrent hyperparathyroidism. In: Cameron, J L, Cameron A. Current Surgical Therapy. 12th ed. Philadelphia, PA: Elsevier, Inc; 2017. :792-797.
  6. Darr, E A, Sritharan N, Pellitteri P K, et al. Management of parathyroid disorders. In: Flint P W, Haughey, B H, Lund V, eds. Cummings Otolaryngology. 6th ed. Philadelphia, PA: Elsevier, Inc; 2015. 124, 1929-1956.e8. :124, 1929-1956.e8.
  7. Doyle, D A. Hyperparathyroidism. In: Kleigman R M, Stanton B F, St Geme, J, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier, Inc; 2016. Chapter 573, 2694-2697.e1. :Chapter 573, 2694-2697.e1.
  8. Fuleihan G E. Patient education: Primary hyperparathyroidism (Beyond the basics). UpToDate. http://www.uptodate.com/. Aug 2017.
  9. Fuleihan G E, Silverberg S J. Primary hyperparathyroidism: Diagnosis, differential diagnosis, and evaluation. UpToDate. http://www.uptodate.com. Aug 2017.
  10. Gerden E M. Parathyroid carcinoma. Operative Techniques in Otolaryngology (2009): Elsevier, Inc; 2009. :20, 79-81.
  11. Hindié E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines. May 12, 2009. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1201-1216. doi: 10.1007/s00259-009-1131-z. Accessed 31 Aug 2017. PMID: 19471928
  12. Maitra, A. The Endocrine System. In: Kumar V, Abbas A K, Aster J C. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia, PA: Saunders, an imprint of Elsevier, Inc.; 2015. :1073-1139.
  13. Quinn C E, Udelsman R. The Parathyroid Gland. In: Townsend, C M, Beauchamp, R, Daniel MD, eds. Sabiston Textbook of Surgery. 20th ed. Philadelphia, PA: Elsevier, Inc; 2017. :923-940.
  14. Silverberg S J, Bilezikian J P. Primary Hyperparathyroidism. In: Jameson J L, De Groot, L J, de Kretser, D M, eds. Endocrinology Adult and Pediatric. 7th ed. Philadelphia, PA: Saunders, an imprint of Elsevier, Inc.; 2016. :Chapter 63, 11-5-1124.e6.
  15. Silverberg S J, Fuleihan G E. Primary hyperparathyroidism: Management. UpToDate. http://www.uptodate.com/. Aug 2017.
  16. Taniegra E D. Hyperparathyroidism. American Academy of Family Physician. 2004 2004;69:333-340. http://www.aafp.org/afp.
  17. Wang, T S, Sosa J A. Secondary and tertiary hyperparathyroidism. In: Cameron J L, Cameron A M. Current Surgical Therapy. 12th ed. Philadelphia, PA: Elsevier, Inc; 2017. :798-802.
  18. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct;151(41):959-968. doi: 10.1001/jamasurg.2016.2310. PMID: 27532368
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Being overweight or obese in adolescence appears to increase the risk of papillary thyroid cancer in adulthood, a recent study has shown.
3 days ago
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Tristan Manalac, 2 days ago
The coronavirus disease 2019 (COVID-19) appears to be more dangerous among cancer patients, who tend suffer more severe complications and faster disease progression, according to a new study.
6 days ago
Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).